Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults

Summary

This is a pilot study to test the efficacy of the anti-inflammatory drug (Fisetin) in reducing inflammatory factors in blood in elderly adults and to test the efficacy of the drug (Fisetin) in reducing frailty and markers of inflammation, insulin resistance, and bone resorption in elderly adults.

Timeline

Start

2018-11-15

Primary completion

2026-11

Completion

2027-11

Drugs

Indications